A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)

Trial Profile

A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Follitropin alfa/lutropin alfa (Primary)
  • Indications Female infertility
  • Focus Adverse reactions
  • Sponsors Merck KGaA
  • Most Recent Events

    • 01 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Feb 2012 Actual initiation date changed from Jul 2011 to Aug 2011 as reported by ClinicalTrials.gov.
    • 14 Feb 2012 Planned End Date changed from 1 Feb 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top